BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Roifman I, Sun YC, Fedwick JP, Panaccione R, Buret AG, Liu H, Rostom A, Anderson TJ, Beck PL. Evidence of endothelial dysfunction in patients with inflammatory bowel disease. Clin Gastroenterol Hepatol. 2009;7:175-182. [PMID: 19121648 DOI: 10.1016/j.cgh.2008.10.021] [Cited by in Crossref: 65] [Cited by in F6Publishing: 67] [Article Influence: 4.6] [Reference Citation Analysis]
Number Citing Articles
1 Yarur AJ, Deshpande AR, Pechman DM, Tamariz L, Abreu MT, Sussman DA. Inflammatory bowel disease is associated with an increased incidence of cardiovascular events. Am J Gastroenterol. 2011;106:741-747. [PMID: 21386828 DOI: 10.1038/ajg.2011.63] [Cited by in Crossref: 146] [Cited by in F6Publishing: 138] [Article Influence: 13.3] [Reference Citation Analysis]
2 Gravina AG, Dallio M, Masarone M, Rosato V, Aglitti A, Persico M, Loguercio C, Federico A. Vascular Endothelial Dysfunction in Inflammatory Bowel Diseases: Pharmacological and Nonpharmacological Targets. Oxid Med Cell Longev 2018;2018:2568569. [PMID: 29849875 DOI: 10.1155/2018/2568569] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
3 Akdoğan RA, Durakoğlugil ME, Kocaman SA, Çiçek Y, Durakoğlugil T, Ergül E, Rakıcı H. Increased pulse wave velocity and carotid intima-media thickness in patients with ulcerative colitis. Dig Dis Sci 2013;58:2293-300. [PMID: 23508984 DOI: 10.1007/s10620-013-2634-9] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 2.1] [Reference Citation Analysis]
4 Erolu E, Polat E. Cardiac functions and aortic elasticity in children with inflammatory bowel disease: effect of age at disease onset. Cardiol Young 2020;30:313-7. [PMID: 31964454 DOI: 10.1017/S1047951119002932] [Reference Citation Analysis]
5 Maracle CX, Agca R, Helder B, Meeuwsen JA, Niessen HW, Biessen EA, de Winther MP, de Jager SC, Nurmohamed MT, Tas SW. Noncanonical NF-κB signaling in microvessels of atherosclerotic lesions is associated with inflammation, atheromatous plaque morphology and myocardial infarction. Atherosclerosis 2018;270:33-41. [DOI: 10.1016/j.atherosclerosis.2018.01.032] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 3.5] [Reference Citation Analysis]
6 Li Z, Qiao L, Yun X, Du F, Xing S, Yang M. Increased risk of ischemic heart disease and diabetes in inflammatory bowel disease. Z Gastroenterol 2021;59:117-24. [PMID: 33233007 DOI: 10.1055/a-1283-6966] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
7 Wu H, Hu T, Zhang L, Xia X, Liu X, Zhu Q, Wang M, Sun Z, Hao H, Cui Y, Parrish AR, Li D, Hill MA, Xu C, Liu Z. Abdominal Aortic Endothelial Dysfunction Occurs in Female Mice With Dextran Sodium Sulfate-Induced Chronic Colitis Independently of Reactive Oxygen Species Formation. Front Cardiovasc Med 2022;9:871335. [DOI: 10.3389/fcvm.2022.871335] [Reference Citation Analysis]
8 Kassam Z, Belga S, Roifman I, Hirota S, Jijon H, Kaplan GG, Ghosh S, Beck PL. Inflammatory bowel disease cause-specific mortality: a primer for clinicians. Inflamm Bowel Dis 2014;20:2483-92. [PMID: 25185685 DOI: 10.1097/MIB.0000000000000173] [Cited by in Crossref: 28] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]
9 Singh S, Singh H, Loftus EV, Pardi DS. Risk of cerebrovascular accidents and ischemic heart disease in patients with inflammatory bowel disease: a systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2014;12:382-93.e1: quiz e22. [PMID: 23978350 DOI: 10.1016/j.cgh.2013.08.023] [Cited by in Crossref: 124] [Cited by in F6Publishing: 111] [Article Influence: 13.8] [Reference Citation Analysis]
10 Üstün Y, Kilincalp S, Çoban Ş, Coşkun Y, Yüksel İ, Ongun A, Soykan İ, Bektaş M, Törüner M, Çetinkaya H, Örmeci N. Evaluation of Early Atherosclerosis Markers in Patients with Inflammatory Bowel Disease. Med Sci Monit 2016;22:3943-50. [PMID: 27773920 DOI: 10.12659/msm.898160] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
11 Lin TY, Chen YG, Lin CL, Huang WS, Kao CH. Inflammatory Bowel Disease Increases the Risk of Peripheral Arterial Disease: A Nationwide Cohort Study. Medicine (Baltimore). 2015;94:e2381. [PMID: 26717386 DOI: 10.1097/md.0000000000002381] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
12 Zanoli L, Rastelli S, Inserra G, Castellino P. Arterial structure and function in inflammatory bowel disease. World J Gastroenterol 2015; 21(40): 11304-11311 [PMID: 26523102 DOI: 10.3748/wjg.v21.i40.11304] [Cited by in CrossRef: 34] [Cited by in F6Publishing: 30] [Article Influence: 4.9] [Reference Citation Analysis]
13 Barnes EL, Beery RM, Schulman AR, McCarthy EP, Korzenik JR, Winter RW. Hospitalizations for Acute Myocardial Infarction Are Decreased Among Patients with Inflammatory Bowel Disease Using a Nationwide Inpatient Database. Inflamm Bowel Dis. 2016;22:2229-2237. [PMID: 27542135 DOI: 10.1097/mib.0000000000000899] [Cited by in Crossref: 23] [Cited by in F6Publishing: 8] [Article Influence: 5.8] [Reference Citation Analysis]
14 Principi M, Mastrolonardo M, Scicchitano P, Gesualdo M, Sassara M, Guida P, Bucci A, Zito A, Caputo P, Albano F, Ierardi E, Di Leo A, Ciccone MM. Endothelial function and cardiovascular risk in active inflammatory bowel diseases. J Crohns Colitis. 2013;7:e427-e433. [PMID: 23473915 DOI: 10.1016/j.crohns.2013.02.001] [Cited by in Crossref: 36] [Cited by in F6Publishing: 40] [Article Influence: 4.0] [Reference Citation Analysis]
15 Kao CC, Lin CL, Huang WY, Cha TL, Lin TY, Shen CH, Kao CH. Association Between Inflammatory Bowel Disease and Erectile Dysfunction: A Nationwide Population-Based Study. Inflamm Bowel Dis 2016;22:1065-70. [PMID: 26863266 DOI: 10.1097/MIB.0000000000000695] [Cited by in Crossref: 16] [Cited by in F6Publishing: 5] [Article Influence: 3.2] [Reference Citation Analysis]
16 Leonetti D, Reimund JM, Tesse A, Viennot S, Martinez MC, Bretagne AL, Andriantsitohaina R. Circulating microparticles from Crohn's disease patients cause endothelial and vascular dysfunctions. PLoS One 2013;8:e73088. [PMID: 24019899 DOI: 10.1371/journal.pone.0073088] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 3.0] [Reference Citation Analysis]
17 Caliskan Z, Keles N, Gokturk HS, Ozdil K, Aksu F, Ozturk O, Kahraman R, Kostek O, Tekin AS, Ozgur GT, Caliskan M. Is activation in inflammatory bowel diseases associated with further impairment of coronary microcirculation? Int J Cardiol 2016;223:176-81. [PMID: 27541650 DOI: 10.1016/j.ijcard.2016.08.141] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
18 Caliskan Z, Gokturk HS, Caliskan M, Gullu H, Ciftci O, Ozgur GT, Guven A, Selcuk H. Impaired coronary microvascular and left ventricular diastolic function in patients with inflammatory bowel disease. Microvasc Res 2015;97:25-30. [PMID: 25128749 DOI: 10.1016/j.mvr.2014.08.003] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 3.0] [Reference Citation Analysis]
19 Shu X, Ji J, Sundquist J, Sundquist K, Hemminki K. Survival in cancer patients hospitalized for inflammatory bowel disease in Sweden. Inflamm Bowel Dis. 2011;17:816-822. [PMID: 20645319 DOI: 10.1002/ibd.21380] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 1.8] [Reference Citation Analysis]
20 Sinh P, Cross R. Cardiovascular Risk Assessment and Impact of Medications on Cardiovascular Disease in Inflammatory Bowel Disease. Inflamm Bowel Dis 2021;27:1107-15. [PMID: 32978937 DOI: 10.1093/ibd/izaa258] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
21 Petriello MC, Hoffman JB, Vsevolozhskaya O, Morris AJ, Hennig B. Dioxin-like PCB 126 increases intestinal inflammation and disrupts gut microbiota and metabolic homeostasis. Environ Pollut 2018;242:1022-32. [PMID: 30373033 DOI: 10.1016/j.envpol.2018.07.039] [Cited by in Crossref: 53] [Cited by in F6Publishing: 45] [Article Influence: 13.3] [Reference Citation Analysis]
22 Javad Hosseinzadeh-attar M, Sharifi A, Nedjat S, Mohamadkhani A, Vahedi H. The Effect of Vitamin D on Serum Asymmetric Dimethylarginine in Patients with Mild to Moderate Ulcerative Colitis. International Journal for Vitamin and Nutrition Research 2020;90:17-22. [DOI: 10.1024/0300-9831/a000303] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
23 Liu W, Ou Y, Yang Y, Zhang X, Huang L, Wang X, Wu B, Huang M. Inhibitory Effect of Punicalagin on Inflammatory and Angiogenic Activation of Human Umbilical Vein Endothelial Cells. Front Pharmacol 2021;12:727920. [PMID: 34867335 DOI: 10.3389/fphar.2021.727920] [Reference Citation Analysis]
24 Kristensen SL, Ahlehoff O, Lindhardsen J, Erichsen R, Jensen GV, Torp-Pedersen C, Nielsen OH, Gislason GH, Hansen PR. Disease activity in inflammatory bowel disease is associated with increased risk of myocardial infarction, stroke and cardiovascular death--a Danish nationwide cohort study. PLoS One. 2013;8:e56944. [PMID: 23457642 DOI: 10.1371/journal.pone.0056944eb] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
25 Patel P, Gao G, Gulotta G, Dalal S, Cohen RD, Sakuraba A, Rubin DT, Pekow J. Daily Aspirin Use Does Not Impact Clinical Outcomes in Patients With Inflammatory Bowel Disease. Inflamm Bowel Dis 2021;27:236-41. [PMID: 32219391 DOI: 10.1093/ibd/izaa060] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
26 Vetter MW, Martin BJ, Fung M, Pajevic M, Anderson TJ, Raedler TJ. Microvascular dysfunction in schizophrenia: a case-control study. NPJ Schizophr 2015;1:15023. [PMID: 27336034 DOI: 10.1038/npjschz.2015.23] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
27 Shen X, Wan Q, Zhao R, Wu Y, Wang Y, Cui Y, Su X, Wu X. Inflammatory bowel diseases and the risk of adverse health outcomes: Umbrella review of meta-analyses of observational studies. Dig Liver Dis 2021;53:809-16. [PMID: 33551353 DOI: 10.1016/j.dld.2021.01.018] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
28 Li Y, Huang X, Guo F, Lei T, Li S, Monaghan-Nichols P, Jiang Z, Xin HB, Fu M. TRIM65 E3 ligase targets VCAM-1 degradation to limit LPS-induced lung inflammation. J Mol Cell Biol 2020;12:190-201. [PMID: 31310649 DOI: 10.1093/jmcb/mjz077] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
29 Rieder F, Kessler SP, West GA, Bhilocha S, de la Motte C, Sadler TM, Gopalan B, Stylianou E, Fiocchi C. Inflammation-induced endothelial-to-mesenchymal transition: a novel mechanism of intestinal fibrosis. Am J Pathol. 2011;179:2660-2673. [PMID: 21945322 DOI: 10.1016/j.ajpath.2011.07.042.] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
30 Zhao S, Liang M, Wang Y, Hu J, Zhong Y, Li J, Huang K, Li Y. Chrysin Suppresses Vascular Endothelial Inflammation via Inhibiting the NF-κB Signaling Pathway. J Cardiovasc Pharmacol Ther 2019;24:278-87. [PMID: 30497287 DOI: 10.1177/1074248418810809] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
31 Philpott AC, Hubacek J, Sun YC, Hillard D, Anderson TJ. Niacin improves lipid profile but not endothelial function in patients with coronary artery disease on high dose statin therapy. Atherosclerosis 2013;226:453-8. [PMID: 23174368 DOI: 10.1016/j.atherosclerosis.2012.10.067] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
32 Mendes RT, Nguyen D, Stephens D, Pamuk F, Fernandes D, Van Dyke TE, Kantarci A. Endothelial Cell Response to Fusobacterium nucleatum. Infect Immun 2016;84:2141-8. [PMID: 27185790 DOI: 10.1128/IAI.01305-15] [Cited by in Crossref: 18] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
33 Cibor D, Domagala-Rodacka R, Rodacki T, Jurczyszyn A, Mach T, Owczarek D. Endothelial dysfunction in inflammatory bowel diseases: Pathogenesis, assessment and implications. World J Gastroenterol 2016; 22(3): 1067-1077 [PMID: 26811647 DOI: 10.3748/wjg.v22.i3.1067] [Cited by in CrossRef: 41] [Cited by in F6Publishing: 36] [Article Influence: 6.8] [Reference Citation Analysis]
34 Schicho R, Marsche G, Storr M. Cardiovascular complications in inflammatory bowel disease. Curr Drug Targets. 2015;16:181-188. [PMID: 25642719 DOI: 10.2174/138945011666650202161500] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
35 Martin B, Gurtu V, Chan S, Anderson TJ. The relationship between peripheral arterial tonometry and classic measures of endothelial function. Vasc Med 2013;18:13-8. [DOI: 10.1177/1358863x12468194] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 1.1] [Reference Citation Analysis]
36 Kristensen SL, Ahlehoff O, Lindhardsen J, Erichsen R, Jensen GV, Torp-Pedersen C, Nielsen OH, Gislason GH, Hansen PR. Disease activity in inflammatory bowel disease is associated with increased risk of myocardial infarction, stroke and cardiovascular death--a Danish nationwide cohort study. PLoS One. 2013;8:e56944. [PMID: 23457642 DOI: 10.1371/journal.pone.0056944] [Cited by in Crossref: 110] [Cited by in F6Publishing: 98] [Article Influence: 12.2] [Reference Citation Analysis]
37 Triantafyllou C, Nikolaou M, Ikonomidis I, Bamias G, Papaconstantinou I. Endothelial and Cardiac Dysfunction in Inflammatory Bowel Diseases: Does Treatment Modify the Inflammatory Load on Arterial and Cardiac Structure and Function? Curr Vasc Pharmacol 2020;18:27-37. [PMID: 30488796 DOI: 10.2174/1570161117666181129095941] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
38 Yuan M, Zhou H, Xiao X, Wang Z, Yao-zhi, Yin X. Inflammatory bowel disease and risk of stroke: A meta-analysis of cohort studies. International Journal of Cardiology 2016;202:106-9. [DOI: 10.1016/j.ijcard.2015.08.190] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
39 Wu GC, Leng RX, Lu Q, Fan YG, Wang DG, Ye DQ. Subclinical Atherosclerosis in Patients With Inflammatory Bowel Diseases: A Systematic Review and Meta-Analysis. Angiology. 2017;68:447-461. [PMID: 27252243 DOI: 10.1177/0003319716652031] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 4.5] [Reference Citation Analysis]
40 Schicho R, Marsche G, Storr M. Cardiovascular complications in inflammatory bowel disease. Curr Drug Targets. 2015;16:181-188. [PMID: 25642719 DOI: 10.2174/1389450116666150202161500] [Cited by in Crossref: 31] [Cited by in F6Publishing: 30] [Article Influence: 5.2] [Reference Citation Analysis]
41 Triantafyllou C, Nikolaou M, Ikonomidis I, Bamias G, Kouretas D, Andreadou I, Tsoumani M, Thymis J, Papaconstantinou I. Effects of Anti-Inflammatory Treatment and Surgical Intervention on Endothelial Glycocalyx, Peripheral and Coronary Microcirculatory Function and Myocardial Deformation in Inflammatory Bowel Disease Patients: A Two-Arms Two-Stage Clinical Trial. Diagnostics (Basel) 2021;11:993. [PMID: 34070768 DOI: 10.3390/diagnostics11060993] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
42 Ferreira-Duarte M, Sousa JB, Diniz C, Sousa T, Duarte-Araújo M, Morato M. Experimental and Clinical Evidence of Endothelial Dysfunction in Inflammatory Bowel Disease. Curr Pharm Des 2020;26:3733-47. [PMID: 32611296 DOI: 10.2174/1381612826666200701212414] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
43 Huang WS, Tseng CH, Chen PC, Tsai CH, Lin CL, Sung FC, Kao CH. Inflammatory bowel diseases increase future ischemic stroke risk: a Taiwanese population-based retrospective cohort study. Eur J Intern Med 2014;25:561-5. [PMID: 24906568 DOI: 10.1016/j.ejim.2014.05.009] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 2.6] [Reference Citation Analysis]
44 Mikirova NA, Jackson JA, Hunninghake R, Kenyon J, Chan KW, Swindlehurst CA, Minev B, Patel AN, Murphy MP, Smith L. Circulating endothelial progenitor cells: a new approach to anti-aging medicine? J Transl Med. 2009;7:106. [PMID: 20003528 DOI: 10.1186/1479-5876-7-106] [Cited by in Crossref: 29] [Cited by in F6Publishing: 24] [Article Influence: 2.2] [Reference Citation Analysis]
45 Park S, Lee HJ, Han KD, Soh H, Moon JM, Hong SW, Kang EA, Im JP, Kim JS. Proteinuria Is Associated with the Development of Crohn's Disease: A Nationwide Population-Based Study. J Clin Med 2021;10:799. [PMID: 33669473 DOI: 10.3390/jcm10040799] [Reference Citation Analysis]
46 Andersen NN, Jess T. Risk of cardiovascular disease in inflammatory bowel disease. World J Gastrointest Pathophysiol 2014; 5(3): 359-365 [PMID: 25133036 DOI: 10.4291/wjgp.v5.i3.359] [Cited by in CrossRef: 19] [Cited by in F6Publishing: 18] [Article Influence: 2.4] [Reference Citation Analysis]
47 Sun X, Icli B, Wara AK, Belkin N, He S, Kobzik L, Hunninghake GM, Vera MP, Blackwell TS, Baron RM, Feinberg MW; MICU Registry. MicroRNA-181b regulates NF-κB-mediated vascular inflammation. J Clin Invest 2012;122:1973-90. [PMID: 22622040 DOI: 10.1172/JCI61495] [Cited by in Crossref: 66] [Cited by in F6Publishing: 226] [Article Influence: 6.6] [Reference Citation Analysis]
48 Zezos P, Kouklakis G, Saibil F. Inflammatory bowel disease and thromboembolism. World J Gastroenterol 2014; 20(38): 13863-13878 [PMID: 25320522 DOI: 10.3748/wjg.v20.i38.13863] [Cited by in CrossRef: 76] [Cited by in F6Publishing: 53] [Article Influence: 9.5] [Reference Citation Analysis]
49 Chung BL, Toth MJ, Kamaly N, Sei YJ, Becraft J, Mulder WJ, Fayad ZA, Farokhzad OC, Kim Y, Langer R. Nanomedicines for Endothelial Disorders. Nano Today 2015;10:759-76. [PMID: 26955397 DOI: 10.1016/j.nantod.2015.11.009] [Cited by in Crossref: 25] [Cited by in F6Publishing: 21] [Article Influence: 3.6] [Reference Citation Analysis]
50 Altorjay I, Veréb Z, Serfozo Z, Bacskai I, Bátori R, Erdodi F, Udvardy M, Sipka S, Lányi Á, Rajnavölgyi É, Palatka K. Anti-TNF-alpha antibody (infliximab) therapy supports the recovery of eNOS and VEGFR2 protein expression in endothelial cells. Int J Immunopathol Pharmacol 2011;24:323-35. [PMID: 21658307 DOI: 10.1177/039463201102400206] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
51 Pepe M, Carulli E, Forleo C, Moscarelli M, Di Cillo O, Bortone AS, Nestola PL, Biondi-Zoccai G, Giordano A, Favale S. Inflammatory Bowel Disease and Acute Coronary Syndromes: From Pathogenesis to the Fine Line Between Bleeding and Ischemic Risk. Inflamm Bowel Dis 2021;27:725-31. [PMID: 32592478 DOI: 10.1093/ibd/izaa160] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
52 Rieder F, Kessler SP, West GA, Bhilocha S, de la Motte C, Sadler TM, Gopalan B, Stylianou E, Fiocchi C. Inflammation-induced endothelial-to-mesenchymal transition: a novel mechanism of intestinal fibrosis. Am J Pathol. 2011;179:2660-2673. [PMID: 21945322 DOI: 10.1016/j.ajpath.2011.07.042] [Cited by in Crossref: 193] [Cited by in F6Publishing: 195] [Article Influence: 17.5] [Reference Citation Analysis]
53 Diamant MJ, Schaffer S, Coward S, Kuenzig ME, Hubbard J, Eksteen B, Heitman S, Panaccione R, Ghosh S, Kaplan GG. Smoking Is Associated with an Increased Risk for Surgery in Diverticulitis: A Case Control Study. PLoS One 2016;11:e0153871. [PMID: 27467077 DOI: 10.1371/journal.pone.0153871] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
54 Goggins BJ, Chaney C, Radford-Smith GL, Horvat JC, Keely S. Hypoxia and Integrin-Mediated Epithelial Restitution during Mucosal Inflammation. Front Immunol 2013;4:272. [PMID: 24062740 DOI: 10.3389/fimmu.2013.00272] [Cited by in Crossref: 31] [Cited by in F6Publishing: 29] [Article Influence: 3.4] [Reference Citation Analysis]
55 Ciccone MM, Principi M, Ierardi E, Di Leo A, Ricci G, Carbonara S, Gesualdo M, Devito F, Zito A, Cortese F. Inflammatory bowel disease, liver diseases and endothelial function: is there a linkage? J Cardiovasc Med (Hagerstown). 2015;16:11-21. [PMID: 25427048 DOI: 10.2459/jcm.0000000000000149] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 2.6] [Reference Citation Analysis]
56 Curione M, Barbato M, Amato S, Pannone V, Maiella G, Parlapiano C, Cucchiara S. Atrioventricular block associated with Crohn's relapsing colitis in a 12-year-old child. Inflamm Bowel Dis 2010;16:373-4. [PMID: 19639557 DOI: 10.1002/ibd.21006] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
57 Konst RE, Guzik TJ, Kaski JC, Maas AHEM, Elias-Smale SE. The pathogenic role of coronary microvascular dysfunction in the setting of other cardiac or systemic conditions. Cardiovasc Res 2020;116:817-28. [PMID: 31977015 DOI: 10.1093/cvr/cvaa009] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 6.0] [Reference Citation Analysis]
58 Kirchgesner J, Beaugerie L, Carrat F, Andersen NN, Jess T, Schwarzinger M; BERENICE study group. Increased risk of acute arterial events in young patients and severely active IBD: a nationwide French cohort study. Gut. 2018;67:1261-1268. [PMID: 28647686 DOI: 10.1136/gutjnl-2017-314015] [Cited by in Crossref: 42] [Cited by in F6Publishing: 35] [Article Influence: 8.4] [Reference Citation Analysis]
59 Singh S, Kullo IJ, Pardi DS, Loftus EV. Epidemiology, risk factors and management of cardiovascular diseases in IBD. Nat Rev Gastroenterol Hepatol. 2015;12:26-35. [PMID: 25446727 DOI: 10.1038/nrgastro.2014.202] [Cited by in Crossref: 60] [Cited by in F6Publishing: 52] [Article Influence: 7.5] [Reference Citation Analysis]
60 Frolkis AD, de Bruyn J, Jette N, Lowerison M, Engbers J, Ghali W, Lewis JD, Vallerand I, Patten S, Eksteen B, Barnabe C, Panaccione R, Ghosh S, Wiebe S, Kaplan GG. The Association of Smoking and Surgery in Inflammatory Bowel Disease is Modified by Age at Diagnosis. Clin Transl Gastroenterol 2016;7:e165. [PMID: 27101004 DOI: 10.1038/ctg.2016.21] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]
61 Ray MK, Fenton CG, Paulssen RH. Novel long non-coding RNAs of relevance for ulcerative colitis pathogenesis. Non-coding RNA Research 2022;7:40-7. [DOI: 10.1016/j.ncrna.2022.02.001] [Reference Citation Analysis]
62 Xiao Z, Pei Z, Yuan M, Li X, Chen S, Xu L. Risk of Stroke in Patients with Inflammatory Bowel Disease: A Systematic Review and Meta-analysis. Journal of Stroke and Cerebrovascular Diseases 2015;24:2774-80. [DOI: 10.1016/j.jstrokecerebrovasdis.2015.08.008] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 3.0] [Reference Citation Analysis]
63 Talero E, Alvarez de Sotomayor M, Sánchez-Fidalgo S, Motilva V. Vascular contribution of adrenomedullin to microcirculatory improvement in experimental colitis. Eur J Pharmacol 2011;670:601-7. [PMID: 21958875 DOI: 10.1016/j.ejphar.2011.09.032] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.3] [Reference Citation Analysis]
64 Jain SS, Shah DK, Gambhire PA, Varma RU, Contractor QQ, Rathi PM. Early atherosclerosis in ulcerative colitis: cross-sectional case-control study. J Dig Dis 2015;16:656-64. [PMID: 26512945 DOI: 10.1111/1751-2980.12297] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
65 Vizzardi E, Gavazzoni M, Della Pina P, Bonadei I, Regazzoni V, Sciatti E, Trichaki E, Raddino R, Metra M. Noninvasive Assessment of Endothelial Function: The Classic Methods and the New Peripheral Arterial Tonometry. Journal of Investigative Medicine 2014;62:856-64. [DOI: 10.1097/jim.0000000000000096] [Cited by in Crossref: 10] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
66 Kayahan H, Sari I, Cullu N, Yuksel F, Demir S, Akarsu M, Goktay Y, Unsal B, Akpinar H. Evaluation of early atherosclerosis in patients with inflammatory bowel disease. Dig Dis Sci. 2012;57:2137-2143. [PMID: 22466100 DOI: 10.1007/s10620-012-2148-x] [Cited by in Crossref: 30] [Cited by in F6Publishing: 27] [Article Influence: 3.0] [Reference Citation Analysis]
67 Winderman R, Rabinowitz SS, Vaidy K, Schwarz SM. Measurement of Microvascular Function in Pediatric Inflammatory Bowel Disease. Journal of Pediatric Gastroenterology & Nutrition 2019;68:662-8. [DOI: 10.1097/mpg.0000000000002252] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 1.7] [Reference Citation Analysis]
68 Huang W, Huang M, Ouyang H, Peng J, Liang J. Oridonin inhibits vascular inflammation by blocking NF-κB and MAPK activation. European Journal of Pharmacology 2018;826:133-9. [DOI: 10.1016/j.ejphar.2018.02.044] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 7.8] [Reference Citation Analysis]
69 Sarı C, Bayram NA, Doğan FEA, Baştuğ S, Bolat AD, Sarı SÖ, Ersoy O, Bozkurt M.d. E. The Evaluation of Endothelial Functions in Patients with Celiac Disease: Endothelial Functions in Celiac Disease. Echocardiography 2012;29:471-7. [DOI: 10.1111/j.1540-8175.2011.01598.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
70 Huang M, Zeng S, Zou Y, Shi M, Qiu Q, Xiao Y, Chen G, Yang X, Liang L, Xu H. The suppression of bromodomain and extra-terminal domain inhibits vascular inflammation by blocking NF-κB and MAPK activation. Br J Pharmacol 2017;174:101-15. [PMID: 27774624 DOI: 10.1111/bph.13657] [Cited by in Crossref: 36] [Cited by in F6Publishing: 35] [Article Influence: 6.0] [Reference Citation Analysis]
71 Saggi S, Lekoubou A, Ovbiagele B. Prevalence and Predictors of Stroke in Patients with Crohn's Disease: A Nationwide Study. J Stroke Cerebrovasc Dis 2021;31:106258. [PMID: 34923435 DOI: 10.1016/j.jstrokecerebrovasdis.2021.106258] [Reference Citation Analysis]